Rapid – Talk Bio

Actionable Insights Powered by AI

Otsuka Pharmaceutical Acquires Jnana Therapeutics for $800M to Develop PKU Treatment

9 months ago talkbio0Tagged Acquisition (action), chemoproteomics, Dosage Forms, Jnana, JNT-517, Metabolic Diseases, Otsuka, Phenylketonurias, PKU, Rapid

Otsuka Pharmaceutical, Jnana Therapeutics, PKU, phenylketonuria, JNT-517, RAPID chemoproteomics platform, rare metabolic disorder, biotech acquisition